Scher, H. I., Graf, R. P., Schreiber, N. A., McLaughlin, B., Jendrisak, A., Wang, Y., . . . Dittamore, R. (2017). Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer. Cancer Res.
Stile di citazione ChicagoScher, Howard I., et al. "Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer." Cancer Res 2017.
Citazione MLAScher, Howard I., et al. "Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer." Cancer Res 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.